Thomas Franchini v. Investor's Business Daily, Inc.

2022 ME 12, 268 A.3d 863
Supreme Judicial Court of Maine·Decided February 10, 2022·Published·Cited by 5 cases

Opinion

MAINE SUPREME JUDICIAL COURT Reporter of Decisions Decision: 2022 ME 12 Docket: Fed-20-306 Argued: September 8, 2021 Decided: February 10, 2022

Panel: STANFILL, C.J., and MEAD, JABAR, HUMPHREY, HORTON, and CONNORS, JJ., and HJELM, A.R.J.

Majority: STANFILL, C.J., and MEAD, JABAR, HUMPHREY, HORTON, and CONNORS, JJ. Dissent: HJELM, A.R.J.

THOMAS FRANCHINI

v.

INVESTOR’S BUSINESS DAILY, INC., et al.

JABAR, J.

[¶1] In this case, we address the First Circuit Court of Appeals’ order certifying a question of law to us: “Should [Investor Business Daily’s] special motion to dismiss be granted under Me. Rev. Stat. tit. 14, § 556 (Maine’s anti-SLAPP law)?” Because there is clear controlling precedent, we decline to consider the question.

I. BACKGROUND

A. Facts

[¶2] The facts, as recited here, are taken from the First Circuit order.

Franchini v. Inv.’s Bus. Daily, 981 F.3d 1 (1st Cir. 2020.) In the 1990s, Investor’s Business Daily (IBD) launched a National Issues feature with the set goal of “not

merely criticizing policies and programs, but also, where possible, putting forward reasonable solutions or policy responses” on “political, regulatory, economic and health care issues” to influence public policy reform at the federal government. This feature started as an editorial page where IBD invited “a well-regarded core of writers, thinkers and policy makers to take part in [the] ‘IBD Brain Trust’” and later “expand[ed] to include op-eds submitted from outside contributors.”

[¶3] Sally Pipes has written “regularly for IBD on health care since the late 1990s,” and is the president and chief executive officer of the Pacific Research Institute, “whose mission is to advance free market-policy solutions to current governmental public policy issues.” Pipes is not an employee of IBD.1 On December 22, 2017, IBD published an op-ed entitled “Sally C. Pipes: VA Negligence Is Killing Veterans”; the byline named Pipes as the op-ed’s author. The op-ed is a general critique of the Department of Veterans Affairs.2

1 It is not clear from the record whether Sally Pipes was a member of the “IBD Brain Trust” or if she was an outside contributor who submitted op-eds. The December 22, 2017, op-ed states that she is a columnist. The First Circuit stated that the district court did not “make any adverse finding of fact relating to IBD’s uncontested declaration that the Sally Pipes Op-Ed was part of an editorial effort to ‘favorably affect[] public policy.’”

2It is not clear how to categorize this piece. The district court referred to it as an article. However, the First Circuit and the declarations refer to it as an op-ed. The published piece stated only that Sally Pipes is a columnist. This opinion will follow the language of the First Circuit and will refer to the piece as an op-ed.

[¶4] The only direct reference to Thomas Franchini was midway through the op-ed:

Consider the case of Thomas Franchini, a podiatrist at a Maine VA hospital. Franchini botched 88 procedures. He severed a patient’s tendon during one surgery and failed to successfully fuse one woman’s ankle in another. The latter’s leg had to be amputated as a result. Franchini wasn’t fired for any of these errors. Instead, the VA allowed him to resign and return to private practice.

The op-ed ended, “The VA is in shambles. Absent reform that allows vets to seek care in the private sector, our veterans will continue to be subjected to subpar care.” Pipes stated that she intended this op-ed to be a “call to action . . . to enlist public participation in the health care policy issues under consideration by national and local governmental bodies.”

[¶5] The op-ed also included an embedded banner reading, “No Hidden Agenda: Get News From a Pro-Free Market, Pro-Growth Perspective.” The end of the op-ed included a biography of Pipes and a hyperlink that stated, “Click here for more Commentary and Opinion from Investor’s Business Daily.” B. Procedure

[¶6] On February 5, 2018, Franchini filed a complaint in the United States District Court for the District of Maine against multiple defendants, including Pipes and IBD. Franchini brought multiple counts against the parties, including defamation and negligent infliction of emotional distress against IBD, and

requested a jury trial. IBD and the other defendants, except for Pipes, moved to dismiss for failure to state a claim.3

[¶7] IBD separately filed a special motion to dismiss arguing that either Maine’s or California’s anti-SLAPP statute applied.4 It included declarations of Pipes and Chris Gessel, the chief content officer of IBD.5 Pipes’s declaration included two exhibits: the op-ed as published and the op-ed with footnotes to sources of the facts.

[¶8] On March 28, 2019, the district court (Singal, J.) denied the special motion to dismiss pursuant to the Maine anti-SLAPP statute and declined to determine whether the California anti-SLAPP statute applied.

The case against Pipes was ultimately dismissed because Franchini failed to timely serve process 3

on her.

4 SLAPP stands for Strategic Lawsuits Against Public Participation, which are lawsuits that are filed with the goal of “stop[ping] citizens from exercising their political rights or to punish them for having done so.” George W. Pring, SLAPPs: Strategic Lawsuits Against Public Participation, 7 Pace Env’t L. Rev. 3, 4-6 (1989). To prevent this infringement on the defendants’ constitutional rights, states have passed anti-SLAPP statutes primarily to address citizen objections to matters of public concern. See Morse Brothers., Inc. v. Webster, 2001 ME 70, ¶ 10, 772 A.2d 842.

5 Under Maine’s anti-SLAPP statute, 14 M.R.S. § 556, courts are to “consider the pleading and supporting and opposing affidavits stating the facts upon which the liability or defense is based.” 14 M.R.S. § 556 (2021). Although the motion was not accompanied by any “affidavits,” both declarations that the district court considered were made pursuant to 28 U.S.C. § 1746, which allows for “any matter required or permitted to be supported, evidenced, established or proved by . . . affidavit” to be made in writing under penalty of perjury. 28 U.S.C.S. § 1746 (LEXIS through Pub. L. 117-80, approved Dec. 27, 2021). Thus, the declarations filed with the federal court are equivalent to affidavits filed in Maine courts.

[¶9] IBD timely appealed the denial of the special motion to dismiss. On November 13, 2020, the First Circuit issued a written order certifying an underlying question of law to us. In the order, the First Circuit stated that the district court did not address IBD’s argument that it was engaged in petitioning activity on its own behalf, which is an issue that “the Gaudette footnote expressly reserved.” See Gaudette v. Mainely Media, LLC (Gaudette II), 2017 ME 87, ¶ 18 n.3, 160 A.3d 539.

[¶10] The First Circuit certified one question to us: “Should IBD’s special motion to dismiss be granted under Me. Rev. Stat. tit. 14, § 556 (Maine’s anti-SLAPP law)?” The First Circuit also “welcome[d] any further comments the Law Court may have on relevant Maine Law.”

II. DISCUSSION

[¶11] Before answering the question certified to us by the First Circuit, we must first decide whether to consider the certified question.

[¶12] Although authorized by 4 M.R.S. § 57 (2021), our consideration of certified questions of law is discretionary. See M.R. App. P. 25; Scamman v. Shaw’s Supermarkets, Inc., 2017 ME 41, ¶¶ 7-8, 157 A.3d 223; Doherty v. Merck & Co., 2017 ME 19, ¶ 8, 154 A.3d 1202; Fortin v. Titcomb, 2013 ME 14, ¶ 3, 60 A.3d 765. We have said that we

may consider the merits of a certified question when three criteria are met: (1) there is no dispute as to the material facts at issue;

(2) there is no clear controlling precedent; and (3) our answer, in at least one alternative, would be determinative of the case.

Scamman, 2017 ME 41, ¶ 7, 157 A.3d 223 (quotation marks omitted).

Free access — add to your briefcase to read the full text and ask questions with AI

Thomas Franchini v. Investor's Business Daily, Inc., 2022 ME 12, 268 A.3d 863 (Me. 2022).

2022 ME 12 (Thomas Franchini v. Investor's Business Daily, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Robert E. Dupuis v. Roman Catholic Bishop of Portland
2025 ME 6 (Supreme Judicial Court of Maine, 2025)
Franchini v. Bangor Publishing Co., Inc.
109 F.4th 13 (First Circuit, 2024)
Cheng v. Neumann
106 F.4th 19 (First Circuit, 2024)
Neal L. Weinstein v. Old Orchard Beach Family Dentistry, LLC
2022 ME 16 (Supreme Judicial Court of Maine, 2022)